Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease
Elaine Ku, Mark J. Sarnak(Tufts Medical Center), Thierry Hannedouche, Charles E. McCulloch(University of California, San Francisco), Tom Greene(University Medical Center Groningen), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), Fan Fan Hou(Southern Medical University), Hiddo J.L. Heerspink(University Medical Center Groningen), Mark Woodward(UNSW Sydney), Philip Kam‐Tao Li(Hospital Authority), Raymond O. Estacio(Denver Health Medical Center), Lesley A. Inker(Tufts Medical Center), Julia B. Lewis, Hocine Tighiouart(Tufts University), Ogechi M. Adingwupu(Tufts Medical Center), Enyu Imai(Takara (Japan)), Tazeen H. Jafar(Apple (Israel)), Dick de Zeeuw(University Medical Center Groningen), Robert D. Toto(Southwestern Medical Center)
Cited by 56
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k